Recombinant Factor VIIa in Acute Intracerebral Haemorrhage
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in North America, Europe, Asia and Oceania. The purpose of this study
is to evaluate safety and efficacy of Recombinant Factor VIIa in patients with acute
intracerebral bleeding.